37th edition – Review of type 2 medicines over DKA risk

Web Version

Forward

TABLE OF CONTENTS

•

Review of type 2 medicines over diabetic ketoacidosis risk

•

Parents urged to cut sugary drinks from children’s diet

•

Treatment for diabetes eye condition advocated by NICE

•

Sanofi Announces First LixiLan Phase III Study Meets Primary Endpoint

•

Nominations open for 'diabetes heroes'

DO YOU HAVE A STORY TO TELL?

GET IN TOUCH

Email your diabetes stories to editor Oliver Jelley.

Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.

Opt in; opt out – Dr Partha Kar’s latest blog post

Before I proceed with this blog, let me lay down a few cards, especially regarding what gives me at least some mileage to pass an opinion.

– I am a consultant in diabetes who has so far:
– Been a consultant in an acute trust contributing to diabetes and general medicine

– Been a consultant working within two community trusts
– Been a clinical manager for an acute trust as well as a community Trust
– Work on a CCG Board
– Work/involved with think tanks such as The King's Fund
– Worked with quangoes eg: NHS Institute of Innovation & Improvement renamed as NHSIQ later

Happy with that? Ok then... here goes.

It's time now for this 7/7 debate to have some pure facts... facts based on experience of working within different formats/organisations, facts away from the raw emotions understandably generated recently. So let's get to the nub.

To read more, click here.

Leicester nurse in ‘eye-opening’ Rwanda trip

A diabetes nurse from Leicester helped to provide free healthcare to more than 200 people during a trip to Rwanda.

Geri Gray, who is a Diabetes Specialist Nurse at the Leicester Diabetes Centre, supported people with type 2 diabetes or at risk of the condition during the week-long personal mission. To read more, click here.

Review of type 2 medicines over diabetic ketoacidosis risk

A review has been launched across Europe into the safety of type 2 diabetes medicines known as SGLT2 inhibitors.

The investigation by The European Medicines Agency (EMA) comes at the request of the European Commission following more than 100 cases of diabetic ketoacidosis (DKA) in people treated with canagliflozin, dapagliflozin and empagliflozin. To read more, click here.

Parents urged to cut sugary drinks from children’s diet

Parents have been advised to cut sugary drinks from their children’s diet and the government has slashed its daily recommended sugar intake by half as part a major new health drive.

Adults and children over 11 years old should consume no more than 30g of sugar a day – less than a single can of Coca Cola – according to long-awaited and final recommendations from the Scientific Advisory Committee on Nutrition (SACN). To read more, click here.

Treatment for diabetes eye condition advocated by NICE

Health watchdog NICE has made the final recommendation for a new treatment for visual impairment due to diabetic macular oedema (DMO).

The health watchdog has given its backing to Bayer HealthCare’s EYLEA® (aflibercept solution for injection). To read more, click here.

Sanofi Announces First LixiLan Phase III Study Meets Primary Endpoint

Sanofi’s combination type 2 diabetes drug LixiLan has met its primary endpoint in its first Phase III trial.

The pharmaceutical firm announced this week that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin. To read more, click here.

Nominations open for 'diabetes heroes'

Nominations are being sought for “special individuals” in an attempt to recognise “diabetes heroes” at a national awards ceremony.

People are being urged to put names forward for both the 2015 Outstanding Educator in Diabetes and the QiC Diabetes People’s Award in the Quality in Care (QiC) diabetes awards programme. To read more, click here.

DIABETES DIGEST

Inhaled formoterol 'reduces' insulin-induced hypoglycaemia

Inhaled formoterol diminishes insulin-induced hypoglycaemia in type 1 diabetes, according to a new study.

The research, published in the American Diabetes Association’s Diabetes Care journal, found that beta 2 adrenergic receptor (AR) agonist formoterol may prevent hypoglycaemia by reducing the effect of insulin. To read more, click here.

Events raise awareness of diabetes

More than 250 people have attended a series of health awareness events organised by a Diabetes Specialist Nurse.

Anna Vanderpuye, from London’s Kings College Hospital, has staged three Health Awareness Days this summer, with the latest taking place on Saturday, July 25, in Walthamstow. To read more, click here.

Novartis responds to rival's NICE endorsement

Novartis has responded to the NICE endorsement of a rival product from Bayer HealthCare by publishing a new health economic analysis report. To read more, click here.

Diabetes course gets top recognition

An education programme for healthcare professionals developed by the Leicester Diabetes Centre has been accredited and rated as “excellent” by a leading general practice association. To read more, click here.

Diabetes UK backs sugar calls

Diabetes UK has backed government recommendations to slash sugar consumption and said everyone needs to "eat less sugar and drink fewer sugary drinks". To read more, click here.

Medtronic and Samsung in US partnership

A ground-breaking partnership in America between Medtronic and Samsung could help improve diabetes management, it has been announced.

To read more, click here.